HPV-vaccine for vaccination of women up to 26 years of age

Nasjonalt Folkehelseinstitutt (FHI) [The Norwegian Institute of Public Health]

The objective of the procurement is to enter into framework agreement for the delivery of HPV vaccine for the vaccination of women up to 26 years of age. The vaccination of this group is a one-off measure, with a duration of two years. Start up for the vaccination is anticipated to be August 2016.
Acquiring vaccination of 6 sets corresponds to offering vaccine to 6 x 30 000 women = 180 000 women.
There is uncertainty surrounding the number of doses as it is dependent on how many women choose to be vaccinated (vaccine coverage).
As a result of this, the volume of the framework agreement spans from 20 % of the estimated coverage to 45 % of the estimated coverage. With three doses per person, this is equivalent to a volume of approx. 108 000 (minimum) — 243 000 doses (maximum). In accordance with the contract, the Contracting Authority is obliged to purchase the minimum volume. Call offs beyond the minimum volume will be dependent on budget coverage and what vaccine coverage is achieved.

Frist

Fristen for mottak av tilbud var 2016-02-29. Anskaffelsen ble publisert 2016-01-18.

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2016-01-18 Kunngjøring av konkurranse
Kunngjøring av konkurranse (2016-01-18)
Gjenstand
Anskaffelsens omfang
Tittel: Vaccines
Antall eller omfang:
There is uncertainty surrounding the number of doses as it is dependent on how many women choose to be vaccinated (vaccine coverage).As a result of this, the volume of the framework agreement spans from 20 % of the estimated coverage to 45 % of the estimated coverage. This is equivalent to a volume of approx. 108 000 (minimum) — 243 000 doses (maximum).The calculation of the procurement's value is based on an estimated price per dose. As a result of this, the calculation of the procurement's value is uncertain.27 000 00061 000 000
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Vaksiner 📦

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Nasjonalt eller føderalt byrå/kontor
Navn på tildelende myndighet: Nasjonalt Folkehelseinstitutt (FHI) [The Norwegian Institute of Public Health]
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21077000 📞

Referanse
Datoer
Sendt dato: 2016-01-18 📅
Innleveringsfrist: 2016-02-29 📅
Publiseringsdato: 2016-01-20 📅
Identifikatorer
Kunngjøringsnummer: 2016/S 013-019538
OJ-S-utgave: 13
Tilleggsinformasjon
Commitment statements (sub-suppliers and other companies for example groups, parent company, sister company, manufacturer etc.). If the tenderer is relying on other companies to meet one or more of the qualification requirements, adequate documentation should be provided to enable the sub-supplier to prove that the relevant requirement has been met. In addition, the tenderer must document that he will have authority over the necessary resources of the other company/companies. Such documentation can be provided by, for example, submitting a signed commitment statement from these companies. Tenderers are requested to register their interest in the case on doffin.no Any additional information, questions and answers will be published on doffin.no and all who have registered their interest will receive automatic notification.
Vis mer

Gjenstand
Anskaffelsens omfang
Estimert verdi eksklusive mva: 27 000 000 💰
61 000 000 💰
Kort beskrivelse:
The objective of the procurement is to enter into framework agreement for the delivery of HPV vaccine for the vaccination of women up to 26 years of age. The vaccination of this group is a one-off measure, with a duration of two years. Start up for the vaccination is anticipated to be August 2016.
Vis mer
Acquiring vaccination of 6 sets corresponds to offering vaccine to 6 x 30 000 women = 180 000 women.
There is uncertainty surrounding the number of doses as it is dependent on how many women choose to be vaccinated (vaccine coverage).
As a result of this, the volume of the framework agreement spans from 20 % of the estimated coverage to 45 % of the estimated coverage. With three doses per person, this is equivalent to a volume of approx. 108 000 (minimum) — 243 000 doses (maximum). In accordance with the contract, the Contracting Authority is obliged to purchase the minimum volume. Call offs beyond the minimum volume will be dependent on budget coverage and what vaccine coverage is achieved.
Vis mer
Antall eller omfang:
There is uncertainty surrounding the number of doses as it is dependent on how many women choose to be vaccinated (vaccine coverage).
As a result of this, the volume of the framework agreement spans from 20 % of the estimated coverage to 45 % of the estimated coverage. This is equivalent to a volume of approx. 108 000 (minimum) — 243 000 doses (maximum).
The calculation of the procurement's value is based on an estimated price per dose. As a result of this, the calculation of the procurement's value is uncertain.
Referansenummer: 15/2976
Utførelsessted
Hovedsted eller utførelsessted: Oslo.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
The tenderer must have the affairs in order with respect to the payment of tax, employer contribution and value added tax (VAT).
The following must be submitted:
‘Certificate for tax and VAT’ issued by the Tax Collector or The Norwegian Tax Administration. The certificate shall not be more than six months when calculated from the tender deadline expiry.
The tenderer must be a legally established company.
Documentation: Company registration certificate.
Økonomisk og finansiell stilling:
Tenderers shall have sufficient financial strength to comply with the contractual obligations.
Documentation requirement:
The service provider's approved annual accounts including notes with the Board's and auditor's reports from the last 2 years.
If the annual accounts for the last year are not finished before the tender deadline expires for this competition, the preliminary annual accounts for the last year shall also be attached.
The Contracting Authority reserves the right to carry out a credit assessment. Financial strength is evaluated in relation to turnover, operating profit margin, solidity and liquidity.
Commitment statement.
If the tenderer is dependent on other companies (groups, parent company, sister company, sub-suppliers, manufacturer etc.) to fulfil this qualification requirement, the tenderer must also deliver the above named documentation for the sub-supplier.
Teknisk og faglig kapasitet:
Tenderers shall have good implementation ability.
Documentation requirement:
Live of the most relevant deliveries during the last three years, including information about the volume, dates and the name of the recipient.
The tenderer shall have sufficient delivery capacity to deliver a minimum of 121 500 doses of HPV vaccine per year.
The tenderers shall submit confirmation that the tenderer (and the sub-tenderer, cf. point 2.1.5 of the tender documentation) has the capacity to deliver at least 121,500 doses per year to the Contracting Authority.
The tenderer shall have a good and relevant quality assurance system for this type of delivery.
A concise description of the overall quality assurance system that the service provider will use for this contract.
Either: A certificate of the company's quality assurance system
issued by independent bodies confirming that
the tenderer meets certain quality assurance standards,
for example NS-EN ISO 9001:2015, or equivalent
Or: Instead of a certificate, other verifiable quality control systems are acceptable where relevant procedures, certificates and deviation/ improvement work emerges.
The supplier shall have the necessary licences. The offered vaccine must be produced by a manufacturer holding authorisation from the relevant authorities in the EU/EEA to manufacture drugs. If the tenderer does not manufacture the vaccine itself, the tenderer must have the necessary authorisation from the relevant authorities in the EU/EEA to trade in pharmaceuticals. If the vaccine is imported, the import licence that covers the offered vaccine must be presented.
Vis mer
— Copy of the manufacturing licence in the manufacturing country, or
— Copy of the sales licence from the relevant authority.
— Copy of the wholesaler or manufacturer licence in Norway.
Kontraktutførelse
Andre særlige vilkår:
For 2016, the tenderer undertakes to deliver at least 27 000 doses by 1.8.2016. (Supply agreement point 3.6)
Resale. After written agreement with the supplier, The Norwegian Institute of Public Health can resell delivered but non distributed vaccine doses when the vaccination is considered carried out. (Supply agreement point 15, 15.1).

Prosedyre
Varighet av rammeavtalen i år: 2
Tilbudets gyldighetsperiode: 090 dager
Dato for åpning av tilbud: 2016-02-29 📅
Åpningssted (organisasjon): The Norwegian Institute of Public Health
Åpningssted: The Archive Unit, sub-archive Myren.
Sted: The Archive Unit, sub-archive Myren.
Tildelingskriterier
Kriterium: 1. Price (60)
2. Quality: including Effect and Security (40)
Språk
Språk: dansk 🗣️
engelsk 🗣️
+ 1 til svensk 🗣️
Andre språk: Norwegian.

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983744516
Kontakt
Kontaktpunkt: Procurement unit
Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://kgv.doffin.no/ctm/Supplier/CompanyInformation/Index/1063 🌏
URL for dokumenter: https://kgv.doffin.no/ctm/Supplier/Documents/Folder/139551 🌏

Referanse
Datoer
Startdato: 2016-04-08 📅
Sluttdato: 2018-04-08 📅
Identifikatorer
Referansenummer tildelt av oppdragsgiver: 15/2976
Tilleggsinformasjon
Commitment statements (sub-suppliers and other companies for example groups, parent company, sister company, manufacturer etc.).
If the tenderer is relying on other companies to meet one or more of the qualification requirements, adequate documentation should be provided to enable the sub-supplier to prove that the relevant requirement has been met. In addition, the tenderer must document that he will have authority over the necessary resources of the other company/companies. Such documentation can be provided by, for example, submitting a signed commitment statement from these companies.
Vis mer
Tenderers are requested to register their interest in the case on doffin.no Any additional information, questions and answers will be published on doffin.no and all who have registered their interest will receive automatic notification.
Kilde: OJS 2016/S 013-019538 (2016-01-18)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Region:
Norge Norge
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner